首页> 外文期刊>American journal of medical genetics, Part A >Lissencephaly: Expanded imaging and clinical classification
【24h】

Lissencephaly: Expanded imaging and clinical classification

机译:播种症:扩展成像和临床分类

获取原文
获取原文并翻译 | 示例
           

摘要

Lissencephaly (“smooth brain,” LIS) is a malformation of cortical development associated with deficient neuronal migration and abnormal formation of cerebral convolutions or gyri. The LIS spectrum includes agyria, pachygyria, and subcortical band heterotopia. Our first classification of LIS and subcortical band heterotopia (SBH) was developed to distinguish between the first two genetic causes of LIS—LIS1 (PAFAH1B1) and DCX. However, progress in molecular genetics has led to identification of 19 LIS‐associated genes, leaving the existing classification system insufficient to distinguish the increasingly diverse patterns of LIS. To address this challenge, we reviewed clinical, imaging and molecular data on 188 patients with LIS‐SBH ascertained during the last 5 years, and reviewed selected archival data on another ~1,400 patients. Using these data plus published reports, we constructed a new imaging based classification system with 21 recognizable patterns that reliably predict the most likely causative genes. These patterns do not correlate consistently with the clinical outcome, leading us to also develop a new scale useful for predicting clinical severity and outcome. Taken together, our work provides new tools that should prove useful for clinical management and genetic counselling of patients with LIS‐SBH (imaging and severity based classifications), and guidance for prioritizing and interpreting genetic testing results (imaging based‐ classification).
机译:展出症(“平滑大脑,”LIS)是一种畸形的皮质发育,与缺乏神经元迁移和脑卷曲或吉尔的形成异常形成。 LIS谱包括亚吡菌,Pachygyria和皮质波动带异偏异性。我们开发了我们的第一次分类LIS和皮质波动带异源(SBH),以区分LIS-LIS1(PAFAH1B1)和DCX的前两个遗传原因。然而,分子遗传学的进展导致了鉴定19个碱基相关基因,留下现有的分类系统不足以区分LIS日益多样化的模式。为了解决这一挑战,我们在过去5年中审查了188例LIS-SBH患者的临床,成像和分子数据,并审查了另一个〜1,400名患者的选定档案数据。使用这些数据加发布的报告,我们构建了一种基于新的成像的分类系统,具有21个可识别的模式,可靠地预测最有可能的致病基因。这些模式与临床结果不一致,导致我们还开发了一种用于预测临床严重程度和结果的新规模。我们的工作共同提供了新的工具,该工具应该证明是对LIS-SBH(成像和严重程度的分类)患者的临床管理和遗传咨询,以及优先考虑和解释基于遗传测试结果的指导(基于成像)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号